From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,757,971 shares, representing 1.11% for $219.35 million under the buyback announced on February 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.21 USD | -0.13% |
|
+7.90% | +0.06% |
07-01 | Bio-Techne Corporation(NasdaqGS:TECH) dropped from Russell Midcap Growth Index | CI |
07-01 | Bio-Techne Corporation(NasdaqGS:TECH) dropped from Russell 3000 Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.06% | 12.17B | |
+22.15% | 46.56B | |
+45.94% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
-8.52% | 11.14B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on February 1, 2022.